Relationship between platelet activation related factors and polymorphism of related genes in patients with coronary heart disease of blood-stasis syndrome

Mei Xue; Ke-ji Chen; Hui-jun Yin

doi:10.1007/s11655-008-0267-1

Your Location：

Home >

Browse articles >

Relationship between platelet activation related factors and polymorphism of related genes in patients with coronary heart disease of blood-stasis syndrome

OriginalPaper | Updated：2021-08-27

- Relationship between platelet activation related factors and polymorphism of related genes in patients with coronary heart disease of blood-stasis syndrome
- Relationship between platelet activation related factors and polymorphism of related genes in patients with coronary heart disease of blood-stasis syndrome
- 中国结合医学杂志（英文版） 2008年14卷第4期页码：267-273
- Affiliations：
  
  Xiyuan Hospital, China Academy of Chinese Medical Sciences,Beijing,China
- Author bio：
- Funds：
  
  Supported by the Major Program Project of National Natural Science Foundation of China (No. 90409021)
- DOI：10.1007/s11655-008-0267-1
  中图分类号：
- 纸质出版日期：2008，
  
  网络出版日期：2008-12-12，
Scan for full text
Xue, M., Chen, Kj. & Yin, Hj. Relationship between platelet activation related factors and polymorphism of related genes in patients with coronary heart disease of blood-stasis syndrome., Chin. J. Integr. Med. 14, 267–273 (2008). https://doi.org/10.1007/s11655-008-0267-1

Mei Xue, Ke-ji Chen, Hui-jun Yin. Relationship between platelet activation related factors and polymorphism of related genes in patients with coronary heart disease of blood-stasis syndrome[J]. Chinese Journal of Integrative Medicine, 2008,14(4):267-273.
Xue, M., Chen, Kj. & Yin, Hj. Relationship between platelet activation related factors and polymorphism of related genes in patients with coronary heart disease of blood-stasis syndrome., Chin. J. Integr. Med. 14, 267–273 (2008). https://doi.org/10.1007/s11655-008-0267-1 DOI：

Mei Xue, Ke-ji Chen, Hui-jun Yin. Relationship between platelet activation related factors and polymorphism of related genes in patients with coronary heart disease of blood-stasis syndrome[J]. Chinese Journal of Integrative Medicine, 2008,14(4):267-273. DOI： 10.1007/s11655-008-0267-1.

摘要

To comparatively study the expressive conditions of platelet activation related factors (GP I b

GP II b- III a and GMP-140) in healthy subjects and patients with coronary heart disease (CHD) of blood-stasis (BS) or non-blood-stasis (non-BS) syndrome

and to analyze the relationship between the activities of various glycoproteins and the polymorphism of genes. With case control design adopted

patients with the CHD (40 of BS

37 of non-BS) and 39 healthy subjects for control

all fitting to the inclusion criteria

were selected in this study. The number of affected coronary branches was recorded by the contrast examination. The mean fluorescence intensity (MFI) of GP I b

GP II b- III a

and GMP-140 (CD42b

CD61

CD62p) in patients and healthy persons was measured with flow cytometry

the polymorphism of HPA-3 gene was detected by Taqman probe technique and that of HPA-2 gene was determined by gene sequencing. MFI of CD61 and CD62p was higher in the CHD patients than in the healthy control

which was also higher in patients of BS syndrome than in patients of non-BS syndrome (P<0.05); MFI of CD42b was lower in the CHD patients than in the healthy control (P<0.05)

but showing insignificant difference between BS and non-BS syndrome (P>0.05); at the same time

no significant difference of all the above-mentioned three MFI could be found in patients with various numbers of affected coronary branches

neither in patients with different genotypes at GP II b HPA-3 and GP I b HPA-2 polymorphism loci (P>0.05). (1) The activities of GP II b- III a and GMP-140 were obviously increased in the genesis and developing process of CHD and CHD of BS syndrome

and so they could be taken as one of the objective indexes for microscopic diagnosis of BS syndrome. (2) The level of GP I b was lower in CHD patients than in healthy persons

but it was not a sensitive indicator for BS syndrome of CHD. (3) Levels of GP II b- III a

GP I b and GMP-140 were not related with the number of affected coronary branches in CHD patients. (4) The changes in amino-acids expression induced by the two loci brought no significant influence on GP I b and GP II b- III a activities.

Abstract

To comparatively study the expressive conditions of platelet activation related factors (GP I b

GP II b- III a and GMP-140) in healthy subjects and patients with coronary heart disease (CHD) of blood-stasis (BS) or non-blood-stasis (non-BS) syndrome

and to analyze the relationship between the activities of various glycoproteins and the polymorphism of genes. With case control design adopted

patients with the CHD (40 of BS

37 of non-BS) and 39 healthy subjects for control

all fitting to the inclusion criteria

were selected in this study. The number of affected coronary branches was recorded by the contrast examination. The mean fluorescence intensity (MFI) of GP I b

GP II b- III a

and GMP-140 (CD42b

CD61

CD62p) in patients and healthy persons was measured with flow cytometry

which was also higher in patients of BS syndrome than in patients of non-BS syndrome (P<0.05); MFI of CD42b was lower in the CHD patients than in the healthy control (P<0.05)

but showing insignificant difference between BS and non-BS syndrome (P>0.05); at the same time

no significant difference of all the above-mentioned three MFI could be found in patients with various numbers of affected coronary branches

and so they could be taken as one of the objective indexes for microscopic diagnosis of BS syndrome. (2) The level of GP I b was lower in CHD patients than in healthy persons

but it was not a sensitive indicator for BS syndrome of CHD. (3) Levels of GP II b- III a

关键词

coronary heart diseaseblood-stasis syndromeGP II b- III aGP I bGMP-140platelet activationgene polymorphism

Keywords

coronary heart diseaseblood-stasis syndromeGP II b- III aGP I bGMP-140platelet activationgene polymorphism

references

Chen HZ, ed. Practical internal medicine. 12th ed. Beijing: People’s Medical Publishing House, 2005:1472–1473.

Society of Cardiology, Chinese Association of the Integration of Traditional and Western Medicine. The diagnostic criteria of TCM in coronary heart disease. Chin J Integr Tradit West Med (Chin) 1991;11(5):257.

Jackson SP, Schoenwaelder SM. Antiplatelet therapy: in search of the ‘magic bullet’. Nat Rev Drug Discov 2003;2:775–789.

Rauch U, Osende JI, Fuster V, et al. Thrombus formation on atherosclerotic plaques: pathogenesis and clinical consequences. Ann Intern Med 2001; 134: 224–238.

Michelson AD, Barnard MR, Krueger LA, et al. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation 2001;104: 1533–1537.

Zhang WG, Yan TX, Gao FJ, et al. Study on Effect of Zhixinkang Capsule (脂欣康胶囊) in treating unstable effort angina and hyperlipidemia and its function in vascular endothelium protection. Chin J Integr Med 2003;9(1): 25–30.

Liu ZG, Yu XY. Effects of Xuezhikang Capsule (血脂康胶囊) on blood lipids, platelet activation and coagulationfibrinolysis activity in patients with hyperlipidemia. Chin J Integr Med 2004;10(4):259–262.

Wang JZ, ed. Applications of flow cytometry in clinical researches. 1st ed. Shanghai: Shanghai Science and Technology Press, 2005: 237.

Tian XY, Liu ZZ, Zhang JL. Relationship between different coronary lesions of unstable angina pectoris and platelet GP II b- III a receptor expression. J Cardiovasc Pulmonary Dis (Chin) 2002;21(1):22–23.

Williams Ms, Ng’alla LS, Vaidya D, et al. Platelet functional implications of glycoprotein I balpha polymorphisms in African Americans. Am J Hematol 2007; 82:15–22.

FULL TEXT LINK

More>

浏览量

355

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Research on the correlation between platelet gelsolin and blood-stasis syndrome of coronary heart disease

Differential gene expression profiles in coronary heart disease patients of blood stasis syndrome in traditional Chinese medicine and clinical role of target gene

Association of platelet-activating factor receptor gene rs5938 (G/T) and rs313152 (T/C) polymorphisms with coronary heart disease and blood stasis syndrome in a Chinese Han population

The diagnostic criteria of blood-stasis syndrome: Considerations for standardization of pattern identification

Blood stasis syndrome of coronary heart disease: A perspective of modern medicine